Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
709.00Today’s High
752.0052W low
492.9052W High
893.00Open Price
735.00Prev. Close
592.1000Volume
50085.00Value
36479409.75Fundamentals
Market Cap
1133.30
Price to Earnings
76.30
Price to Book Value
2.20
Dividend Yield
0.10
PE to Growth
-1.60
Op Revenue TTM
272.98
Net Profit TTM
14.86
Cash From Operating Activity
-6.36
Return on Equity %
3.22
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
53.8
Week
33
Month
44.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
734.83
PIVOT
First Resistance
746.42
Second Resistance
763.63
Third Resistance
775.22
First Support
717.62
Second Support
706.03
Third Support
688.82
Relative Strength Index
71.29
Money Flow Index
92.46
MACD
32.54
MACD Signal
16.88
Average True Range
34.44
Average Directional Index
25.35
Rate of Change (21)
28.71
Rate of Change (125)
2.14
Commodity Channel Index
186.6
Williams %R
-23.2
BETA
1 Month
0.97
3 Month
1.15
1 Year
0.97
3 Year
PRICE CHANGE ANALYSIS
↑ 15.05%
1 Week
Low
High
621
777.8
↑ 23.95%
1 Month
Low
High
566
777.8
↑ 25.66%
3 Months
Low
High
535.05
777.8
↑ 2.96%
6 Months
Low
High
492.9
777.8
↓ -5.1%
1 Year
Low
High
492.9
893
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 24.84 | 24.40 | 23.52 | 22.57 | 24.81 | 22.61 | 23.13 | 25.23 | 26.91 | 27.36 | 24.17 | |
| Operating Expenses Qtr | 20.38 | 19.76 | 18.49 | 18.11 | 20.63 | 17.68 | 17.64 | 18.56 | 20.06 | 21.26 | 18.40 | |
| Operating Profit Qtr | 3.54 | 3.97 | 5.01 | 4.42 | 3.63 | 4.10 | 5.16 | 6.18 | 5.32 | 5.63 | 5.77 | |
| EBIDT Qtr Cr | 4.46 | 4.64 | 5.03 | 4.46 | 4.18 | 4.94 | 5.49 | 6.67 | 6.84 | 6.09 | 5.77 | |
| Depreciation Qtr | 1.34 | 1.21 | 1.62 | 1.12 | 1.19 | 1.35 | 1.22 | 1.48 | 1.32 | 1.35 | 1.29 | |
| Net Profit Qtr | 2.56 | 2.31 | 1.17 | 2.53 | 3.31 | 2.89 | 4.04 | 4.87 | 5.40 | 4.59 | 4.38 | |
| Basic EPS Qtr | 1.68 | 1.55 | 0.79 | 1.75 | 2.28 | 1.99 | 2.79 | 3.36 | 3.73 | 3.17 | 3.18 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 95.33 | 95.78 | 101.29 | 85.24 | 61.98 | |
| Operating Expenses Annual Cr | 76.74 | 74.51 | 76.10 | 66.14 | 51.33 | |
| Operating Profit Annual | 16.94 | 19.07 | 23.21 | 18.73 | 9.44 | |
| Operating Profit Margin Annual % | 17.77 | 19.91 | 22.91 | 21.97 | 15.23 | |
| Total Expenses Annual Cr | 85.25 | 81.16 | 82.43 | 72.71 | 53.26 | |
| EBIDT Annual Cr | 18.59 | 21.27 | 25.19 | 19.11 | 10.64 | |
| EBIDT Annual margin % | 19.50 | 22.21 | 24.87 | 22.41 | 17.17 | |
| Depreciation | 5.28 | 5.24 | 5.24 | 6.06 | 1.01 | |
| PAT Before ExtraOrdinary Items Annual Cr | 8.58 | 15.10 | 19.36 | 12.68 | 8.75 | |
| Net Profit Annual | 8.58 | 15.10 | 19.36 | 12.68 | 8.75 | |
| Basic EPS Annual | 5.63 | 10.42 | 13.69 | 9.20 | 6.35 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 374.04 | 290.81 | 273.23 | 180.00 | 167.65 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 23.45 | 12.87 | 3.89 | 5.16 | 0.52 | |
| Total Current Liabilities Annual Cr | 73.88 | 60.99 | 40.47 | 37.45 | 18.18 | |
| Total Capital Plus Liabilities Annual Cr | 471.37 | 364.67 | 317.58 | 222.61 | 186.35 | |
| Fixed Assets Annual | 238.96 | 182.87 | 131.47 | 120.35 | 79.12 | |
| Total Non Current Assets Annual | 332.74 | 260.80 | 197.52 | 183.34 | 128.52 | |
| Total Current Assets Annual | 138.63 | 103.87 | 120.06 | 39.27 | 57.83 | |
| Total Assets Annual | 471.37 | 364.67 | 317.58 | 222.61 | 186.35 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.06 | 0.06 | 0.06 | 0.06 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 0.47 | -12.66 | 7.02 | 46.00 | -7.08 | |
| Cash from Investing Activity Annual | -80.25 | -64.89 | -16.50 | -61.28 | -64.65 | |
| Cash from Financing Annual Activity | 92.84 | 20.51 | 75.52 | 10.22 | -8.77 | |
| Net Cash Flow Annual | - | -57.04 | 66.05 | -5.06 | -80.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 240.38 | 200.70 | 188.57 | 130.63 | 121.67 | |
| ROE Annual % | 2.29 | 5.19 | 7.08 | 7.04 | 5.22 | |
| ROCE Annual % | 3.34 | 5.28 | 7.20 | 7.04 | 5.72 | |
| Total Debt to Total Equity Annual | 0.12 | 0.12 | 0.05 | 0.06 | 0.00 | |
| EBDIT Annual Margin % | 19.84 | 22.73 | 25.37 | 22.51 | 17.51 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 72.73 | 71.74 | 67.61 | 64.89 | 63.83 | 58.82 | 57.19 | 59.28 | 50.00 | 60.82 | 57.17 | |
| Operating Expenses Qtr | 61.95 | 61.37 | 57.39 | 53.10 | 52.81 | 47.38 | 45.33 | 45.99 | 37.85 | 47.59 | 44.69 | |
| Operating Profit Qtr | 9.29 | 8.86 | 9.66 | 11.37 | 10.12 | 9.98 | 11.01 | 11.84 | 10.29 | 11.93 | 12.00 | |
| EBIDT Qtr Cr | 10.78 | 10.37 | 10.22 | 11.79 | 11.02 | 11.44 | 11.86 | 13.29 | 12.15 | 13.23 | 12.48 | |
| Depreciation Qtr | 3.11 | 3.01 | 3.44 | 2.81 | 2.81 | 2.95 | 2.83 | 3.01 | 2.85 | 2.92 | 2.64 | |
| Net Profit Qtr | 3.44 | 3.06 | 1.88 | 6.48 | 7.08 | 6.66 | 5.53 | 8.46 | 8.15 | 8.37 | 8.61 | |
| Basic EPS Qtr | 2.26 | 2.03 | 1.26 | 2.28 | 2.28 | 3.27 | 3.81 | 4.40 | 4.51 | 4.28 | 4.44 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 276.96 | 239.11 | 218.46 | 198.71 | 189.42 | |
| Operating Expenses Annual Cr | 233.80 | 191.50 | 168.00 | 159.63 | 157.73 | |
| Operating Profit Annual | 39.18 | 42.94 | 46.75 | 37.95 | 28.55 | |
| Operating Profit Margin Annual % | 14.15 | 17.96 | 21.40 | 19.10 | 15.07 | |
| Total Expenses Annual Cr | 253.81 | 207.45 | 181.50 | 169.79 | 162.72 | |
| EBIDT Annual Cr | 43.16 | 47.61 | 50.46 | 39.08 | 31.69 | |
| EBIDT Annual margin % | 15.58 | 19.91 | 23.10 | 19.67 | 16.73 | |
| Depreciation | 12.38 | 11.60 | 11.01 | 8.58 | 3.51 | |
| PAT Before ExtraOrdinary Items Annual Cr | 18.07 | 29.83 | 34.25 | 24.66 | 22.04 | |
| Net Profit Annual | 16.36 | 21.24 | 25.61 | 17.60 | 14.01 | |
| Basic EPS Annual | 10.75 | 14.66 | 18.12 | 12.77 | 10.16 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 507.57 | 360.39 | 287.19 | 179.08 | 176.28 | |
| Minority Interest Liability Annual Cr | 0.00 | 58.89 | 77.49 | 80.42 | 73.27 | |
| Total Non Current Liabilities Annual Cr | 26.46 | 15.40 | 10.42 | 12.75 | 3.99 | |
| Total Current Liabilities Annual Cr | 158.44 | 143.56 | 113.16 | 90.72 | 74.67 | |
| Total Capital Plus Liabilities Annual Cr | 692.47 | 578.24 | 488.26 | 362.97 | 328.21 | |
| Fixed Assets Annual | 330.81 | 275.53 | 223.95 | 209.99 | 153.31 | |
| Total Non Current Assets Annual | 398.56 | 316.69 | 248.36 | 232.25 | 170.60 | |
| Total Current Assets Annual | 293.91 | 261.56 | 239.90 | 130.72 | 157.61 | |
| Total Assets Annual | 692.47 | 578.24 | 488.26 | 362.97 | 328.21 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.06 | 0.06 | 0.06 | 0.06 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -6.36 | -18.95 | 11.13 | 58.77 | 5.72 | |
| Cash from Investing Activity Annual | -85.81 | -70.77 | -23.36 | -79.09 | -101.95 | |
| Cash from Financing Annual Activity | 99.24 | 49.63 | 78.21 | 16.06 | 10.29 | |
| Net Cash Flow Annual | - | -40.09 | 65.99 | -4.26 | -85.93 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 326.19 | 289.37 | 251.69 | 188.32 | 181.10 | |
| ROE Annual % | 3.22 | 5.89 | 8.91 | 9.82 | 7.94 | |
| ROCE Annual % | 5.76 | 8.28 | 10.51 | 11.20 | 11.11 | |
| Total Debt to Total Equity Annual | 0.15 | 0.16 | 0.13 | 0.16 | 0.06 | |
| EBDIT Annual Margin % | 15.80 | 20.30 | 23.49 | 19.78 | 17.01 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Growel Remedies Limited | 47.95 | 74196146 | 0 | 2.28 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| IEGFL- Multi Oportunity | 1.33 | 74196151 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Megharaj Jain Shikar | 1.32 | 74196158 |
| FL Dadabhoy | 1.07 | 74196159 |
| HUF | 1.96 | 74196153 |
| Eric Aarestrup Sorensen | 2.15 | 74196167 |
| Sanjay Bansal | 1.93 | 74196165 |
| Ginnerup Capital ApS | 5.18 | 74196162 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 22, 2023 | 0.5 | FINAL | - | Equity Share |
| Sep 21, 2022 | 0.5 | FINAL | - | Equity Share |
| Sep 17, 2021 | 0.5 | FINAL | - | Equity Share |
| Sep 18, 2020 | 0.25 | FINAL | - | Equity Share |
| Sep 20, 2019 | 0.5 | FINAL | - | Equity Share |
| Sep 19, 2018 | 0.5 | FINAL | - | Equity Share |
| Sep 04, 2017 | 1 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Apr 19, 2018 | 10:5 | 2018-04-20 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 29, 2024 | Audited Results & Final Dividend | - |
| Feb 12, 2024 | Quarterly Results | - |
| Nov 10, 2023 | Quarterly Results | - |
| Aug 08, 2023 | Quarterly Results | - |
| Jun 03, 2023 | Preferential issue of shares | - |
| May 29, 2023 | Audited Results & Final Dividend | - |
| Feb 10, 2023 | Quarterly Results | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 25, 2022 | Audited Results & Final Dividend | - |
| Feb 08, 2022 | Quarterly Results | - |
| Nov 03, 2021 | Quarterly Results | - |
| Oct 14, 2021 | Preferential issue of shares | - |
| Aug 13, 2021 | Quarterly Results | - |
| Aug 11, 2021 | Preferential issue of shares | - |
| Jun 26, 2021 | Audited Results | - |
| Feb 12, 2021 | Quarterly Results | - |
| Nov 13, 2020 | Quarterly Results | - |
| Aug 13, 2020 | Quarterly Results | - |
| Jun 30, 2020 | Audited Results & Final Dividend | - |
| Feb 06, 2020 | Quarterly Results | - |
| Nov 08, 2019 | Quarterly Results | - |
| Aug 14, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results & Final Dividend | - |
| Feb 11, 2019 | Quarterly Results | - |
| Nov 13, 2018 | Quarterly Results | - |
| Sep 27, 2018 | Preferential Issue of shares | - |
| Jul 25, 2018 | Quarterly Results & Final Dividend | - |
| May 30, 2018 | Audited Results | - |
| May 07, 2018 | Others | Inter alia, to issue Equity Shares on Preferential Allotment basis to the promoter and non-promoter group entities. |
| Apr 10, 2018 | Others | - |
| Mar 05, 2018 | Bonus issue & Stock Split | - |
| Feb 12, 2018 | Quarterly Results | - |
| Nov 10, 2017 | Quarterly Results | - |
| Aug 02, 2017 | Quarterly Results | - |
| Jul 31, 2017 | Quarterly Results | - |
| Jul 17, 2017 | Others | In the EGM, all the items of business mentioned in the notice were duly considered and discussed. |
| Jun 21, 2017 | Others | 1.To issue of convertible Warrants into Equity Shares on Preferential Allotment basis to a promoter group and non promoter group. 2.To call an Extra Ordinary General Meeting. |
| May 27, 2017 | Audited Results & Final Dividend | - |
| Feb 10, 2017 | Quarterly Results | - |
| Nov 14, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results | - |
| Feb 12, 2016 | Quarterly Results | - |
| Nov 14, 2015 | Quarterly Results | - |
| Sep 16, 2015 | Others | To considered and approved the proposal to acquire substantial stake and control over M/s. Medicamen Biotech Limited, a company listed on BSE Limited. |
| Aug 14, 2015 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Apr 19, 2018 | 1:4 | 2018-04-20 |
04 Jul 2024
Shivalik Rasayan Ltd - 539148 - Clarification sought from Shivalik Rasayan Ltd
The Exchange has sought clarification from Shivalik Rasayan Ltd on July 4, 2024, with reference to Movement in Volume.The reply is awaited.
29 Jun 2024
Shivalik Rasayan Ltd - 539148 - Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015
Form C received from Ms. Manju Bansal w/o Mr. Sanjay Bansal, Director of the Company regarding transfer of 21500 Equity shares by way of gift.
27 Jun 2024
Shivalik Rasayan Ltd - 539148 - Closure of Trading Window
Intimation of Trading Window Closure
26 Jun 2024
Shivalik Rasayan Ltd - 539148 - Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015
Intimation as per Regulation 7(3) of SEBI PIT Regulations, 2015
31 May 2024
Shivalik Rasayan Ltd - 539148 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for the quarter and year ended Financial Results as on 31.03.2021
29 May 2024
Shivalik Rasayan Ltd - 539148 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report as on 31.0.2024
29 May 2024
Shivalik Rasayan Ltd - 539148 - Compliances As Per Reg 32
Statement of Deviation as on 31.03.2024
29 May 2024
Shivalik Rasayan Ltd - 539148 - Board Meeting Outcome for Approval Of Financial Results For Quarter And Year Ended On 31.03.2024 And Recommendation Of Final Dividend
Approval of financial results for the quarter and year ended on 31.03.2024 and recommendation of Final Dividend for the FY 2023-24
29 May 2024
Shivalik Rasayan Ltd - 539148 - Audited Results For The FY 2023-24
Approval of Audited Financial Results for the quarter and year ended on 31.03.2024 and recommendation of Final Dividend for the FY 2023-24
21 May 2024
Shivalik Rasayan Ltd - 539148 - Board Meeting Intimation for Approval Of Quarterly And Yearly Financial Results (Standalone & Consolidated) For The Year Ended On 31.03.2024
Shivalik Rasayan Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Financial results (standalone & consolidated) for the quarter and year ended on 31.03.2024 and to recommend final dividend for the FY 2023-24.
